Yu-Ching Lee Selected Research

3,6- bis(5- chloro- 2- piperidyl)- 2,5- piperazinedione

1/2016

TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Ching Lee Research Topics

Disease

18	Neoplasms (Cancer) 03/2022 - 01/2010
6	Snake Bites (Snake Bite) 11/2020 - 05/2015
4	Hyperpigmentation 07/2015 - 11/2014
3	Ovarian Neoplasms (Ovarian Cancer) 03/2022 - 01/2022
3	Ovarian Epithelial Carcinoma 03/2022 - 01/2022
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015 - 11/2014
2	Stroke (Strokes) 05/2022 - 01/2021
2	Papillary Carcinoma 03/2022 - 01/2022
2	Leukemia 10/2019 - 01/2017
1	Lymphatic Metastasis 04/2022
1	Disease Progression 03/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	COVID-19 01/2021
1	Invasive Candidiasis 04/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Meningitis 07/2019
1	Female Infertility 01/2019
1	Endometriosis 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Wounds and Injuries (Trauma) 12/2016
1	Malaria 01/2016
1	Vascular System Injuries 01/2016
1	Hyperplasia 01/2016
1	Glucose Intolerance 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Human Influenza (Influenza) 10/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Rheumatoid Arthritis 01/2013
1	Purpura 01/2013
1	Thrombocytopenia (Thrombopenia) 01/2013
1	Lung Neoplasms (Lung Cancer) 10/2010
1	Fibrosarcoma 01/2010
1	Inflammation (Inflammations) 10/2009
1	Severe Acute Respiratory Syndrome 05/2007

Drug/Important Bio-Agent (IBA)

6	AntibodiesIBA 08/2021 - 10/2010
4	Therapeutic UsesIBA 03/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 08/2021 - 10/2010
4	Melanins (Melanin)IBA 07/2015 - 11/2014
3	Hematoxylin (Haematoxylon)IBA 04/2022 - 01/2022
3	Eosine Yellowish-(YS) (Eosin)IBA 04/2022 - 01/2022
3	Bevacizumab (Avastin)FDA Link 03/2022 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 12/2019
3	Monoclonal AntibodiesIBA 01/2022 - 01/2020
3	Antivenins (Antivenoms)IBA 11/2020 - 12/2016
3	Monophenol Monooxygenase (Tyrosinase)IBA 02/2015 - 11/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2020
2	Neutralizing AntibodiesIBA 01/2021 - 10/2015
2	Single-Chain AntibodiesIBA 11/2020 - 12/2016
2	Phosphopyruvate Hydratase (Enolase)IBA 04/2020 - 10/2010
2	IgYIBA 12/2016 - 10/2010
2	EnzymesIBA 02/2015 - 11/2014
2	CosmeticsIBA 02/2015 - 11/2014
2	CopperIBA 02/2015 - 11/2014
1	Epidermal Growth Factor (EGF)IBA 03/2021
1	B7-H1 AntigenIBA 01/2020
1	CateninsIBA 12/2019
1	OMPA outer membrane proteinsIBA 07/2019
1	Estrogen ReceptorsIBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	MPT0L145IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	VenomsIBA 10/2017
1	Anti-Arrhythmia AgentsIBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	Cardiac GlycosidesIBA 01/2017
1	Digoxin (Digitek)FDA LinkGeneric 01/2017
1	lanatoside CIBA 01/2017
1	1-benzylindoleIBA 01/2017
1	Antimalarials (Antimalarial Agents)IBA 01/2016
1	3,6- bis(5- chloro- 2- piperidyl)- 2,5- piperazinedioneIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	EpitopesIBA 10/2015
1	Hemagglutinins (Hemagglutinin)IBA 10/2015
1	Skin Lightening PreparationsIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2013
1	Peptides (Polypeptides)IBA 01/2010
1	Amino Acids FDA Link 01/2010
1	Transcription Factors (Transcription Factor)IBA 10/2009
1	NF-kappa B (NF-kB)IBA 10/2009

Therapy/Procedure

7	Therapeutics 03/2022 - 05/2007
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
3	Immunotherapy 08/2021 - 12/2019
2	Thrombectomy 05/2022 - 01/2021
1	Aftercare (After-Treatment) 03/2022
1	Precision Medicine 01/2018
1	Oral Administration 01/2016
1	Intravenous Injections 01/2010